CN Patent

CN113614232A — 动态药代动力学修饰锚

Assigned to University of Massachusetts Amherst · Expires 2021-11-05 · 5y expired

What this patent protects

提供了包含药代动力学(PK)修饰锚的治疗性寡核苷酸。提供了用于治疗疾病或病症的方法，其包括向对象施用包含一种或更多种PK修饰锚的治疗性寡核苷酸。

USPTO Abstract

提供了包含药代动力学(PK)修饰锚的治疗性寡核苷酸。提供了用于治疗疾病或病症的方法，其包括向对象施用包含一种或更多种PK修饰锚的治疗性寡核苷酸。

Drugs covered by this patent

inclisiran-sodium (INCLISIRAN SODIUM)

Patent Metadata

Patent number: CN113614232A
Jurisdiction: CN
Classification: —
Expires: 2021-11-05
Drug substance claim: No
Drug product claim: No
Assignee: University of Massachusetts Amherst
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.